Phase 3 Study to Evaluate IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertension C-02-41

This study has been completed.

First Received: October 8, 2002 Last Updated: August 4, 2008 History of Changes

Sponsor:	Alcon Research
Information provided by:	Alcon Research
ClinicalTrials.gov Identifier:	NCT00047528

Purpose

To compare intraocular pressure lowering effectiveness of a combination drug vs. two individual drugs dosed alone.

Condition	Intervention	Phase
Open-Angle Glaucoma Ocular Hypertension	Drug: Alcon Investigational Agent	Phase III

Study Type:	Interventional
Study Design:	Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:	Phase III Safety and Efficacy Study to Evaluate Combination IOP Lowering Therapy in Open Angle Glaucoma and Ocular Hypertensive Patients (C-02-41).

Resource links provided by NLM:

Genetics Home Reference related topics: early-onset glaucoma

MedlinePlus related topics: Glaucoma High Blood Pressure

U.S. FDA Resources

Further study details as provided by Alcon Research:

Study Start Date:	January 2001
Study Completion Date:	November 2003
Primary Completion Date:	November 2003 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; visual acuity of 20/80 to 20/400 or better (Snellen equivalent) or logMAR visual acuity not worse than 0.6. Clinically relevant ophthalmic or systemic conditions may be excluded.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00047528

Locations

United States, Texas
Clinical Trial Sites
Fort Worth, Texas, United States, 76134

Sponsors and Collaborators

Alcon Research

More Information

No publications provided

Study ID Numbers:	C-02-41, C-02-41
Study First Received:	October 8, 2002
Last Updated:	August 4, 2008
ClinicalTrials.gov Identifier:	NCT00047528 History of Changes
Health Authority:	United States: Food and Drug Administration

Keywords provided by Alcon Research:

open-angle
glaucoma
ocular
hypertension
POAG

Additional relevant MeSH terms:

Glaucoma
Eye Diseases
Glaucoma, Open-Angle
Vascular Diseases

Cardiovascular Diseases
Ocular Hypertension
Hypertension

ClinicalTrials.gov processed this record on November 27, 2009